Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on August 24, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on August 24, 2026; holds 333,943 after (Indirect).
- Open-market sale: disposed of 224 Common Stock at $509.41 ($114,108) on August 24, 2026; holds 333,719 after (Indirect).
- Open-market sale: disposed of 1,323 Common Stock at $510.52 ($675,421) on August 24, 2026; holds 332,396 after (Indirect).
- Open-market sale: disposed of 3,056 Common Stock at $511.63 ($1,563,538) on August 24, 2026; holds 329,340 after (Indirect).
- Open-market sale: disposed of 3,592 Common Stock at $512.46 ($1,840,743) on August 24, 2026; holds 325,748 after (Indirect).
- Open-market sale: disposed of 1,305 Common Stock at $513.35 ($669,921) on August 24, 2026; holds 324,443 after (Indirect).
- Option exercise/conversion: disposed of 9,500 Stock Option on August 24, 2026; holds 75,410 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $4,863,730 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 333,943 |
| 2026-08-24 | Open-market sale | Common Stock | 224 | $509 | $114.1K | 333,719 |
| 2026-08-24 | Open-market sale | Common Stock | 1,323 | $511 | $675.4K | 332,396 |
| 2026-08-24 | Open-market sale | Common Stock | 3,056 | $512 | $1.6M | 329,340 |
| 2026-08-24 | Open-market sale | Common Stock | 3,592 | $512 | $1.8M | 325,748 |
| 2026-08-24 | Open-market sale | Common Stock | 1,305 | $513 | $669.9K | 324,443 |
| 2026-08-24 | Option exercise/conversion | Stock Option | 9,500 | — | — | 75,410 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Option exercise/conversion (9,500 shares) |
| 2026-08-24 | Open-market sale (224 shares) |
| 2026-08-24 | Open-market sale (1,323 shares) |
| 2026-08-24 | Open-market sale (3,056 shares) |
| 2026-08-24 | Open-market sale (3,592 shares) |
| 2026-08-24 | Open-market sale (1,305 shares) |
| 2026-08-24 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.